Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis
- 10 April 2007
- journal article
- Published by Wiley in Parasite Immunology
- Vol. 29 (5) , 251-258
- https://doi.org/10.1111/j.1365-3024.2007.00940.x
Abstract
SUMMARY: Cutaneous (CL) and mucosal leishmaniasis (ML) are characterized by a predominant type 1 immune response (IFN‐γ and TNF‐α production) and strong inflammatory response in the lesions with few parasites. This exacerbated type 1 response is more evident in ML as compared to CL. Our main hypothesis is that a differential immune regulation of T cell activation leads to over reactive T cells in ML. In the present study, we investigated immunological factors that could explain the mechanisms behind it by comparing some immune regulatory mechanisms between ML and CL patients: frequency of cells expressing co‐stimulatory molecules, apoptotic markers, T cell activation markers; and ability of neutralizing antibodies to IL‐2, IL‐12 and IL‐15 do down‐regulate IFN‐γ production in leishmania antigen‐stimulated peripheral blood mononuclear cells (PBMC). Interestingly, in CL anti‐IL‐2 and anti‐IL‐15 significantly suppressed antigen‐specific IFN‐γ production, while in ML only anti‐IL‐2 suppressed IFN‐γ production. Finally, higher frequency of CD4+ T cells expressing CD28−, CD69+ and CD62L low were observed in ML as compared to CL. These data indicate that an exacerbated type 1 response in ML is differentially regulated and not appropriately down modulated, with increased frequencies of activated effectors T cells, maintaining the persistent inflammatory response and tissue damage observed in ML.Keywords
This publication has 36 references indexed in Scilit:
- Decreased In Situ Expression of Interleukin-10 Receptor Is Correlated with the Exacerbated Inflammatory and Cytotoxic Responses Observed in Mucosal LeishmaniasisInfection and Immunity, 2005
- Modulation of T-Cell Costimulation as Immunotherapy or Immunochemotherapy in Experimental Visceral LeishmaniasisInfection and Immunity, 2003
- Infectious Agent and Immune Response Characteristics of Chronic Enterocolitis in Captive Rhesus MacaquesInfection and Immunity, 2003
- Regulation of Staphylococcus epidermidis-induced IFN-γ in whole human blood: the role of endogenous IL-18, IL-12, IL-1, and TNFCytokine, 2003
- Randomized, Double‐Blind Study of Stibogluconate Plus Human Granulocyte Macrophage Colony‐Stimulating Factor versus Stibogluconate Alone in the Treatment of Cutaneous LeishmaniasisThe Journal of Infectious Diseases, 1999
- Interleukin-12 Restores Interferon- Production and Cytotoxic Responses in Visceral LeishmaniasisThe Journal of Infectious Diseases, 1996
- Tumor necrosis factor-α in human American tegumentary leishmaniasisMemórias do Instituto Oswaldo Cruz, 1996
- Interaction between the Innate and the Acquired Immune System following Infection of Different Mouse Strains with Leishmania majorAnnals of the New York Academy of Sciences, 1994
- Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens.The Journal of Experimental Medicine, 1988
- Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.Journal of Clinical Investigation, 1985